These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 26039005

  • 1. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
    Cho E, Jun CH, Kim BS, Son DJ, Choi WS, Choi SK.
    Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
    [Abstract] [Full Text] [Related]

  • 2. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW, Yun M, Cho A, Han KH, Kim DY, Lee SM, Lee JD.
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.
    Kim MJ, Kim YS, Cho YH, Jang HY, Song JY, Lee SH, Jeong SW, Kim SG, Jang JY, Kim HS, Kim BS, Lee WH, Park JM, Lee JM, Lee MH, Choi DL.
    Korean J Intern Med; 2015 May; 30(3):308-15. PubMed ID: 25995661
    [Abstract] [Full Text] [Related]

  • 5. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH.
    Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Value of 18-FDG-positron emission tomography/computed tomography before and after transarterial chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: initial results.
    Cascales Campos P, Ramirez P, Gonzalez R, Febrero B, Pons JA, Miras M, Sanchez Bueno F, Robles R, Parrilla P.
    Transplant Proc; 2011 Apr; 43(6):2213-5. PubMed ID: 21839236
    [Abstract] [Full Text] [Related]

  • 9. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
    Ma W, Jia J, Wang S, Bai W, Yi J, Bai M, Quan Z, Yin Z, Fan D, Wang J, Han G.
    Theranostics; 2014 Apr; 4(7):736-44. PubMed ID: 24883123
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma.
    Lee JW, Paeng JC, Kang KW, Kwon HW, Suh KS, Chung JK, Lee MC, Lee DS.
    J Nucl Med; 2009 May; 50(5):682-7. PubMed ID: 19372474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
    Huang WY, Kao CH, Huang WS, Chen CM, Chang LP, Lee MS, Chao HL, Chiu CH, Lo CH, Jen YM.
    J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
    [Abstract] [Full Text] [Related]

  • 15. Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation.
    Boussouar S, Itti E, Lin SJ, Decaens T, Evangelista E, Chiaradia M, Chalaye J, Baranes L, Calderaro J, Laurent A, Pigneur F, Duvoux C, Azoulay D, Costentin C, Rahmouni A, Luciani A.
    Cancer Imaging; 2016 Feb 16; 16():4. PubMed ID: 26883745
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with Barcelona Clinic Liver Cancer stages 0 and A hepatocellular carcinomas: a multicenter retrospective cohort study.
    Hyun SH, Eo JS, Lee JW, Choi JY, Lee KH, Na SJ, Hong IK, Oh JK, Chung YA, Song BI, Kim TS, Kim KS, Moon DH, Yun M.
    Eur J Nucl Med Mol Imaging; 2016 Aug 16; 43(9):1638-45. PubMed ID: 26936852
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in predicting treatment response in unresectable hepatocellular carcinoma patients treated with external beam radiotherapy.
    Kim JW, Seong J, Yun M, Lee IJ, Yoon HI, Cho HJ, Han KH.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1172-8. PubMed ID: 21570203
    [Abstract] [Full Text] [Related]

  • 18. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J, Schroeder O, Raedle J, Baum RP, Herrmann G, Jacobi V, Zeuzem S.
    Am J Gastroenterol; 1999 Nov 01; 94(11):3314-9. PubMed ID: 10566736
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
    Lee JW, Oh JK, Chung YA, Na SJ, Hyun SH, Hong IK, Eo JS, Song BI, Kim TS, Kim DY, Kim SU, Moon DH, Lee JD, Yun M.
    J Nucl Med; 2016 Apr 01; 57(4):509-16. PubMed ID: 26742711
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma.
    Detry O, Govaerts L, Deroover A, Vandermeulen M, Meurisse N, Malenga S, Bletard N, Mbendi C, Lamproye A, Honoré P, Meunier P, Delwaide J, Hustinx R.
    World J Gastroenterol; 2015 Mar 14; 21(10):3049-54. PubMed ID: 25780305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.